Navigation Links
Aoxing Pharmaceutical Company Has No Comment on Unusual Trading Activity
Date:6/23/2011

nts is inherently uncertain, and the Company's actual results may differ materially due to a number of factors, many of which are beyond its ability to predict or control, including, among many others, the Company's ability to commercialize on the patent subject of this press release, its ability to develop new therapeutic delivery methods, to complete GMP certification of the workshops, obtain process approvals, develop the product line as and when anticipated. These forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual events to differ from the forward-looking statements. More information about some of these risks and uncertainties may be found in the reports filed with the Securities and Exchange Commission by the Company. The Company operates in a highly competitive and rapidly changing business and regulatory environment, thus new or unforeseen risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. These forward-looking statements are based on the Company's current expectations and beliefs concerning future developments and their potential effects on the Company. There can be no assurance that future developments affecting the Company will be those anticipated by the Company. The Company undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

CONTACT:  

Aoxing Pharmaceutical Company:
Bob Ai
Chief Financial Officer
646-367-1767
investor.relations@aoxingpharma.com

Investor Relations:
The Trout Group
Brian Korb
646-378-2923
bkorb@troutgroup.com


'/>"/>
SOURCE Aoxing Pharmaceutical Company, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Biostar Pharmaceuticals, Inc. Receives Patent for Aoxing Ganbao
2. QRxPharma Limited and China Aoxing Pharmaceutical Company Announce Strategic Alliance for Development of MoxDuo(R)IV
3. Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 , ... Dr. Ra from Biostar , Published in ,Stem ... increase of lifespan through multiple IV administration of Adipose-derived ... and life expectancy found , Commercialization within 5 ... determined the possibility that adult mesenchymal stem cells (MSCs) ...
(Date:8/27/2015)... Va. , Aug. 27, 2015  The ... the Food and Drug Administration,s (FDA,s) draft guidance ... reference products and biosimilars, to bear a nonproprietary ... AMCP has been seeking a decision from the ... 18 diverse health care stakeholders urging the agency ...
(Date:8/27/2015)... , August 27, 2015 According to a ... Hammock, Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), ... to 2020", published by MarketsandMarkets, the Medical Lifting Sling Market is ... Million in 2015, at a CAGR of 11.4 % from 2015 ... ma rket data T ables and ...
Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
(Date:8/28/2015)... ... 2015 , ... Saint Petersburg, FL —Pocket Protein™, a protein ... sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch that never ... Choice Awards. , Five consumer packaged goods (CPG) products were selected by the ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... nationwide. Addictions specialist, Dr. James Strawbridge, gives a new approach on solutions in ... should begin with the employer and employees getting together for meaningful group meetings. ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... three-year accreditation for its adolescent residential, counseling, day treatment and intensive family based ... meets international standards for quality and its pursuit of excellence. As a nonprofit ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Quatela Center for Plastic Surgery is ... and only nonsurgical product approved by the Food and Drug Administration to eliminate submental ... Dr. William Koenig are among the premier cosmetic surgeons in Rochester to ...
(Date:8/28/2015)... ... 28, 2015 , ... SharkNinja, an innovative leader in the ... actress, Sofia Vergara, and unveil the Ninja® brand’s new coffee machine, the ... a variety of sizes and styles while achieving the perfect brew richness level ...
Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3
... PARIS and MARSEILLE, France, January 11 ... signing of a,scientific collaboration agreement in the breast cancer domain. ... Ipsogen,s,MapQuant Dx Grade Genomic, HER2 and HR tests will be ... patients treated at the Institut,Curie. The aim of this collaboration ...
... , CHICAGO, Jan. 11 ... Stimulus Program , making it safe and easy for physicians ... qualify for significant federal incentives. , (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ... a guarantee that the Allscripts EHR they select will meet ...
... , , ... MDRX ) announced today that Renaissance Medical Management Company (RMMC) ... Practice Management solution to automate and connect clinical and ... medicine physicians. The new service offering from RMMC builds upon the ...
... ... months and shared his story on ABC,s Good Morning America on January 8, 2010 , ... New York, NY (PRWEB) January 11, 2010 -- ... ago, kicked off 2010 with an appearance on ABC,s Good Morning America last Friday, feeling and ...
... ... simply spelling correctly the Hebrew word Sun ( SheMeSh éÞé) in English Letters as ... ... years of research, Joseph Lanyadoo concludes that language was neither invented by humans ...
... , CHICAGO, Jan. 10 Allscripts-Misys Healthcare ... for the three and six months ended November 30, 2009. ... Highlights: , Total revenue of $169.3 million; non-GAAP ... cents; non-GAAP earnings per share of $0.16 cents Net income ...
Cached Medicine News:Health News:The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer 2Health News:The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer 3Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 2Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 3Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 4Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 5Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 6Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 2Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 3Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 4Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 5Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 6Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 7Health News:Happy New Year for Marty: Arizona Man Drops 164 Pounds on Dr. Siegal's COOKIE DIET and Appears on ABC's Good Morning America 2Health News:Happy New Year for Marty: Arizona Man Drops 164 Pounds on Dr. Siegal's COOKIE DIET and Appears on ABC's Good Morning America 3Health News:New 20 Year Research Confirms the Biblical Assertion that Hebrew is the Original Proto-Language Confounded By the Gods 2Health News:New 20 Year Research Confirms the Biblical Assertion that Hebrew is the Original Proto-Language Confounded By the Gods 3Health News:New 20 Year Research Confirms the Biblical Assertion that Hebrew is the Original Proto-Language Confounded By the Gods 4Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 13Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 14Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 15Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 16Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 17Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 18
... flexible care settings., ,IntelliVue MP40 ... and measurement flexibility to match the ... care environmentsat the patients side., ... patient monitoring, IntelliVue has highly flexible ...
... Built on Philips strong heritage in patient ... an extensive clinical measurements menu; built-in clinical ... derived 12-lead ECG, and arrhythmia analysis; and ... easy to use and operates on a ...
... to match the pace and unique needs ... on Philips strong heritage in patient monitoring, ... has highly flexible screen configuration; an extensive ... such as Event Surveillance, EASI derived 12-lead ...
... expands hospital-grade monitoring capabilities into the growing ... disease state management. The system is ... full range of clinical applications, from continuous ... to periodic monitoring of patients outside the ...
Medicine Products: